Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Abivax
Company

Abivax

Tracked across 1 events · 7 articles · First seen Feb 21, 2026 · Last active Feb 21, 2026

Sentiment
70
Attention
4
Events
1
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 70
Tech
Abivax Presents Positive Obefazimod Data at ECCO
Abivax announced positive preclinical and clinical data for its lead drug candidate, obefazimod, at the ECCO 2026 congress. These findings highlight obefazimod's anti-fibrotic potential in Crohn's disease, favorable safety profile, and rapid symptomatic relief, strengthening confidence in its development for inflammatory bowel disease.
Feb 21, 2026 · 7 articles
Relationships (2)
Fabio Cataldi Chief Medical Officer ↔ Abivax Fabio Cataldi is the Chief Medical Officer of Abivax.
Marc de Garidel Chief Executive Officer ↔ Abivax Marc de Garidel is the Chief Executive Officer of Abivax.
NEWSDESK
Track Abivax live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.